Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life

Sleep Medicine

Volumn 11, Issue 10, 2010, Pages 1043-1048

  Benediktsdottir, Bryndis ^a,c   Janson, Christer ^b   Lindberg, Eva ^b   Arnardóttir, Erna Sif ^a,c   Olafsson, Isleifur ^c   Cook, Elizabeth ^c   Thorarinsdottir, Elin Helga ^a   Gislason, Thorarinn ^a,c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UPPSALA UNIVERSITY   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

CRP; Epidemiology; Ferritin; Hypertension; IL 6; Lung function; Quality of life; Restless legs syndrome

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRITIN; INSULIN; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; EPWORTH SLEEPINESS SCALE; ETHNICITY; FEMALE; FERRITIN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERTENSION; ICELAND; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SEX DIFFERENCE; SLEEP DISORDER; SMOKING; SPIROMETRY; SWEDEN;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; FERRITINS; HUMANS; HYPERTENSION; ICELAND; INFLAMMATION; INTERLEUKIN-6; LUNG DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SMOKING; SPIROMETRY; SWEDEN;

EID: 78649450110     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.08.006     Document Type: Article

References (36)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the national Institutes of Health. Sleep Med 2003, 4:101-119.
2. Hogl B., Willeit J., et al. Restless legs syndrome: a community-based study of prevalence, severity and risk factors. Neurology 2005, 64:1920-1924.
3. Hening W., Walters A.S., Allan R.P., Montplaisir J., Myers A., Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in primary care population: the REST (RLS epidemiology, symptoms and treatment) primary care study. Sleep Med 2004, 5:237-246.
4. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165:1286-1292.
5. Trenkwalder C., Högl B., Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009, 256(4):539-553.
6. Tison F., Crochard A., Leger D., Bouee S., Lainey E., El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 2005, 65:239-246.
7. Kim J., Choi C., Shin K., et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: The Korean Health and Genome Study. Psychiatry Clin Neurosci 2005, 59:350-353.
8. Nichols D.A., Allen R.P., Grauke J.H., Brown J.B., Rice M.L., Hyde P.R., et al. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003, 163:2323-2329.
9. Stefansson H., Rye D.B., Hicks A., et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357:639-647.
10. Winkelmann J., Scormair B., Lichtner P., et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39:1000-1006.
11. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004, 5:385-391.
12. Beard J.L., Connor J.R. Iron status and neural functioning. Annu Rev Nutr 2003, 23:41-58.
13. Sun E.R., Chen C.A., Ho G., Earley C.J., Allen R.P. Iron and the restless legs syndrome. Sleep 1998, 21(4):371-377.
14. O'Keeffe S.T., Gavin K., Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 1994, 23:200-203.
15. Trenkwalder C., Högl B., Benes H., Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008, 9:572-574.
16. Connor J.R. Pathophysiology of restless legs syndrome: evidence for iron involvement. Curr Neurol Neurosci Rep 2008, 8(2):162-166.
17. Phillips B., Young T., Finn L., et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000, 160:2137-2141.
18. Berger K., Luedemann J., Trenkwalder C., et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004, 164:196-202.
19. Sevim S., Dogu O., Camdeviren H., et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003, 61:1562-1569.
20. Lavigne G.L., Lobbezoo F., Rompre P.H., et al. Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep 1997, 20:290-293.
21. Kaplan Y., Inonu H., Yilmaz A., Ocal S. Restless legs syndrome in patients with chronic obstructive pulmonary disease. Can J Neurol Sci 2008, 35(3):352-357.
22. Lo Coco D., Mattaliano A., Lo Coco A., Randisi B. Increased frequency of restless legs syndrome in chronic obstructive pulmonary disease patients. Sleep Med 2009, 10(5):572-576.
23. Ulfberg J., Nyström B., Carter N., Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001, 46:17-19.
24. Buist A.S., McBurnie M.A., Vollmer W.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
25. Johns M.W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992, 15:376-381.
26. Partinen M., Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): a quantitative measure of subjective sleep complaints. J Sleep Res 1995, 4:150-155.
27. Gislason T., Almqvist M. Somatic disease and sleep complaints - an epidemiological study of 3201 Swedish men. Acta Med Scand 1987, 221:475-481.
28. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999, 159(1):179-187.
29. Bjorvatn B., Leissner L., Ulfberg J., Gyring J., Karlsborg M., Regeur L., et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 2005, 6(4):307-312.
30. Jonsson J.J., Johannesson G.M., Sigfusson N., Magnusson B., Thjodleifsson B., Magnusson S. Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol 1991, 44(12):1289-1297.
31. Borch-Johnsen B., Sandstad B., Asberg A. Iron status among 3005 women aged 20-55 years in Central Norway: The Nord-Trøndelag Health Study (the HUNT Study). Scand J Clin Lab Invest 2005, 65:45-54.
32. Trenkwalder C., Högl B., Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009, 256:539-553.
33. Wouters E.F. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(1):26-33.
34. Hening W., Caivano C. Restless legs syndrome: a common disorder in patients with rheumatologic conditions. Semin Arthritis Rheum 2008, 38(1):55-62.
35. Barnes P.J., Celli B.J. Systemic manifestations and comorbidities of COPD. Review. Eur Respir J 2009, 33:1165-1185.
36. Brown L.K., Dedrick D.L., Doggett J.W., Guido P.S. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005, 6(5):443-450.